ICM
OGN icon

Invenomic Capital Management’s Organon & Co OGN Stock Holding History

Invenomic Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,951
Closed -$605K – 178
2023
Q4 		$605K Sell
41,951
-204,866
-83% -$2.79M 0.03% 170
2023
Q3 		$4.28M Buy
+246,817
New +$5.15M 0.18% 103
2022
Q4 		– Sell
-270,313
Closed -$6.33M – 161
2022
Q3 		$6.33M Buy
+270,313
New +$8.16M 0.54% 61

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invenomic Capital Management's OGN Position: Q1 2024 in Review

Invenomic Capital Management sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 41,951 shares — an estimated $605K sold.

Invenomic Capital Management first reported a position in OGN in Q3 2022 and held it in 3 quarters. The position peaked at $6.33M in Q3 2022. 721 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Invenomic Capital Management reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 41,951 Organon & Co shares in Q1 2024, an estimated $605K.
  • Invenomic Capital Management first reported a position in Organon & Co in Q3 2022 and held it in 3 quarters.
  • Invenomic Capital Management's Organon & Co position peaked at $6.33M in Q3 2022.
  • 721 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.